Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by gebremeskelon Dec 01, 2016 11:47am
148 Views
Post# 25540628

RE:Piece of cake...

RE:Piece of cake...Actually, the treatment had high efficacy.

It destroyed the cancer.

Unfortunately, it also left the bladder unuseable.

wildbird1 wrote:

.........

- Unfortunately the treatment was refused by HC, because of low efficacy, side effects and damages to the bladder walls.

-Now, Dr Jewett (with 8 more years of experience working with PDC) will repeat the same treatment, but this time with a new PDC (TLD-1433), which is 198 times more effective than Phototrin and has no side effects and no toxicity.

- He will also have at his disposal a new laser system that will deliver more effectively the light throughout the cancer tumor.

- And this new treatment will be done in one of the top cancer center in the world (Princess Margaret Cancer Center).

- Wow... No wonder Dr Jewett in his interview on Korelin sounded so optimistic about the human trials.

- We can presume that with the experience of Dr Jewett, the new PDC (TLD-1433), the new laser system and the help of Princess Margaret Cancer Center, the human trials are going to be a '' Piece of cake''.

(still long)



Bullboard Posts